Professional Documents
Culture Documents
com | Medicine
Immunology of Endocrine Disease
Important to have
• Engagement of TCR (TCR Signal)
• Co-stimulatory Signals
Co-Stimulatory Molecules
• CD28 (on T-cell ) ←→ B7
• CD40L (on T-cell) ←→ CD40
Absence of Co-Stimulatory Signals
• T-cell Unresponsiveness (Anergy)
• Apoptosis (Programmed Cell Death) = Deletion
jslum.com | Medicine
Thyroid Autoimmune Disease
Hashimoto’s Thyroiditis Grave’s Disease Primary Hypothyroidism Transient Thyroiditis Syndromes
Organ-specific Autoimmune disorder Autoimmune disorders of unknown cause Most common cause of Hypothyroidism in Adults Self limited Thyroiditis syndrome with transient immune activity against Thyroid
Unknown cause Presents as Thyrotoxicosis with a Diffuse goiter Female ↑ Subacute Thyroiditis Post Partum Thyroiditis
rd th
Results in Progressive Destruction of Thyroid Most common in 3 , 4 decades of life 40 – 60 y/o Caused by Viral Infection of Thyroid Gland Occurs in 5-8% of Pregnant Women
Female Predominance Female ↑ Atrophy from unrecognized Thyroiditis with resulting Acute Phase Characterized by
1/10 Middle-Aged Women Occur in 0.1-0.5% of general population Progressive Destruction of Gland Gland may be Painful Development of Transient Thyrotoxicosis
st
Elderly, Children (can also be affected) Strong associations with Lab Investigations Antithyroid Antibodies may be present Hypothyroidism during 1 3 months of post partum
Families with History of Whites Asians ↑ TSH ↑ T4 Significant % develop Chronic Thyroid Dysfunction
Autoimmune Thyroid Disease DR3 Bw35 ↓ Thyroid Hormones Thyrotoxic Assocation with
Associated with DQβ Bw46 Immunologic Features Progressive Euthyroid, Hypothyroid periods HLA-DR3 Haplotype
SLE DQa Lymphocytic infiltration of Thyroid Gland Then Thyroid Function Normalize HLA-DR5 Haplotype
Chronic Active Hepatitis Anti-Thyroid Antibodies (>80% of patients) Feature
Dermatitis Herpetiformis Immunopathogenesis Treatment Silent Thyroiditis without Pain
Scleroderma Presence of an autoantibody that Lifelong Thyroid Hormone replacement Immunologic Features Immunologic Features
Strong Associations with recognizes TSH Receptor Antibodies to Thyroid Peroxidase Antibodies to Thyroid Peroxidase
HLA DR4 Mediates stimulation of receptor (both – Transient, Low Titer in Subacute Thyroiditis) (both – Transient, Low Titer in Subacute Thyroiditis)
HLA DR5 (eg. Grave’s disease) Thyroid Stimulating Antibodies
Inhibition of receptor activation by TSH Treatment Treatment (clinically Hypothyroid)
Immunopathogenesis (Unclear) (Thyroid Function back to Normal within few months) (Thyroid Function back to Normal within few months)
Cellular Immunity Clinical Features Anti-Inflammatory drugs Thyroid Hormone Replacement
Antibody-Dependent Cytotoxicity Uniformly Enlarged Diffuse Goiter
Clinical Features Signs of Hyperthyroidism
Euthyroidism (Early disease) • Tremor
Clinical Hyperthyroidism • Tachycardia
(due to Inflammatory Breakdown of Thyroid Follicles • Heat Intolerance
with release of Thyroid Hormone) • Nervousness
Hypothyroidism (Late disease) • Warm Moist Skin
(due to Progressive Destruction of Opthalmopathy
Thyroid Gland) • Lid Lag
• Proptosis
Dermopathy
• Pretibial area (Myxedema)
Immunological Features
Monocytic, Lymphocytic Infiltration of Islets of Langerhans
+ve for Anti-Glutamic Acid Decarboxylase Antibody
+ve Islet Cells Antibody
+ve Anti-Insulin Autoantibody (IAA) (Type IA Disease)
HLA-DR expression on β cells
↑ Apoptosis of β cells
Diagnosis
Clinical Signs, Symptoms
Hyperglyc aemia
Osmotic Diuresis (Polyuria, Polydypsia)
Insulin Deficiency
↓
Utilization of Fats for Fuel
↓
Metabolism of Fatty Acids
↓
Ketoacids Production
↓
Ketonuria
Ketonaemia
Ketoacidosis with Cerebral Edema
Unexplained Weight Loss
↑HbA1c (Glycosylated Hb conc)
Severe impairment of Insulin Secretion
Fasting C-peptide (Proinsulin) not detectable
Presence of Islet Cell Autoantibodies against Autoantigens
Insulin
Glutamic Acid Decarboxylase
ICA
Treatment
Oral Hypoglycaemia drugs (Normalize Blood Glucose level)
Insulin replacement
Islet Cell Transplantation (future)
Immunosuppressive therapy
jslum.com | Medicine
Autoimmune Polyglandular Syndromes
Syndrome
Type I Type II Type III
(Mucocutaneous Candidiasis Endocrinopathy) (Schmidt’s Syndrome)
Major Criteria Major Criteria Major Criteria
Candidiasis Adrenal Failure Thyroid Disease
Adrenal Failure Thyroid Disease
Hypoparathyroidism IDDM
Minor Criteria Minor Criteria Minor Criteria
Gonadal Failure Gonadal Failure IDDM
Alopecia Vitiligo Gastric Disease
Malabsorption Nonendocrine AD Neuroendocrine AD
Chronic Hepatitis
Epidemiology Epidemiology Epidemiology
Female ↑ Female ↑ Least Well Characterized
Childhood < 10 y/o 20 – 30 y/o Most Common disorder
Female ↑
Most common associations Idiopathic Addison’s Disease with presence of Presence of Autoimmune Thyroid Disease with other AID
Candidiasis (>70%) Diabetes IDDM
Hypoparathyroidism (>70%) Thyroid Disease Gastric Disease
Adrenal Insufficiency (40 – 70%) Both (Diabetes, Thyroid Disease) Non-Endocrine AID (eg. Myasthenia Gravis)
Other associations Gonadal Failure (↓% of cases) Associated with HLA
Chronic Active Hepatitis Association with HLA-DR3
Alopecia Areata Familial – Mode of Inheritance is Unknown
Pernicious Anaemia
Gonadal Failure
Pathogenesis (Unknown)
Fungal Infection (cell-mediated immunity defect)
Auto-Antibodies are seen
Not associated with HLA Haplotype